应《网络安全法》要求，自2017年10月1日起，未进行实名认证将不得使用互联网跟帖服务。为保障您的帐号能够正常使用，请尽快对帐号进行手机号验证，感谢您的理解与支持！

24小时热门版块排行榜    

小木虫论坛-学术科研互动平台 » 生物医药区 » 新药研发 » 快捷药讯 » 【讨论】非索非那定的市场情况
51/1返回列表
查看: 1941  |  回复: 5
只看楼主 @他人 存档 新回复提醒 (忽略) 收藏    在APP中查看
当前只显示满足指定条件的回帖，点击这里查看本话题的所有回帖

空城若虚

金虫 (正式写手)

[交流] 【讨论】非索非那定的市场情况

求：非索非那定的
  一、产品研发背景
1. 原研厂家
2. 研发时间与研究立意
3.国外的上市与销售情况
  
二、与现有竞争产品的比较

三、国内市场情况
1.批文数量及厂家（含规格）
2. 历史销售情况及分析
3.国内主要生产厂家的销售情况
回复此楼

» 猜你喜欢

» 本主题相关价值贴推荐，对您同样有帮助:

» 抢金币啦！回帖就可以得到:

查看全部散金贴
1楼 2011-03-18 12:15:14
已阅   回复此楼   关注TA 给TA发消息 送TA红花 TA的回帖

空城若虚

金虫 (正式写手)
请版主取消这个帖子吧
时间太久了，已经不需要了
谢谢！
赞一下 回复此楼
6楼2011-03-29 08:47:19
已阅   回复此楼   关注TA 给TA发消息 送TA红花 TA的回帖
查看全部 6 个回答

nkbeholder

木虫 (正式写手)
我靠，这也行。
我觉得这东西你自己搞一下比较好，又不难。
赞一下 回复此楼
2楼2011-03-18 12:51:27
已阅   回复此楼   关注TA 给TA发消息 送TA红花 TA的回帖

robbiekean

木虫 (正式写手)
★ ★ ★
warlen(金币+1): 谢谢参与 2011-03-18 15:54:09
空城若虚(金币+40): 非常感谢！ 2011-03-18 20:13:20
caoyuan521(金币+2): 谢谢参与！ 2011-03-18 21:04:15
引用回帖:
Originally posted by 空城若虚 at 2011-03-18 12:15:14:
求：非索非那定的
  一、产品研发背景
1. 原研厂家
2. 研发时间与研究立意
3.国外的上市与销售情况
  
二、与现有竞争产品的比较

三、国内市场情况
1.批文数量及厂家（含规格）
2. 历史销售情况 ...

Fexofenadine hydrochloride
Cas number: 153439-40-8, 138452-21-8

- General description:

Fexofenadine (trade names Allegra, Telfast, Fastofen, Tilfur, Vifas, Telfexo, Allerfexo) is an antihistamine drug used in the treatment of hayfever and similar allergy symptoms. It was developed as a successor of and alternative to terfenadine (trade names include Triludan and Seldane), an antihistamine which caused QT interval prolongation, potentially leading to cardiac arrhythmia.

It has been described as both second-generation[3] and third-generation antihistamine.

The older antihistaminic agent terfenadine was found to metabolize into the related carboxylic acid, fexofenadine. Fexofenadine was found to retain all of the biological activity of its parent while giving fewer adverse reactions in patients, so terfenadine was replaced in the market by its metabolite.[8] Fexofenadine was originally synthesized in 1993 by Massachusetts-based biotechnology company Sepracor, which then sold the development rights to Hoechst Marion Roussel (now part of Sanofi-Aventis), and was later approved by the Food and Drug Administration (FDA) in 1996. AMRI holds the patents to the intermediates and production of fexofenadine HCl along with Roussel. Since that time, it has achieved blockbuster drug status with global sales of $1.87B USD in 2004 (with $1.49B USD coming from the United States). AMRI received royalty payments from Aventis that enabled the growth of AMRI.

On January 25, 2011, the FDA approved over-the-counter sales of fexofenadine in the United States, with Sanofi-Aventis' version expected to become available on March 4, 2011.


I. Originator:Aventis Pharma, Sepracor;
   Marketer:  ViroPharma;
   Reference patent: JP 1996502022; WO 9321156;



II. Main Competitors in U.S:
N021963   Yes FEXOFENADINE HYDROCHLORIDE SUSPENSION; ORAL 30MG/5ML ALLEGRA SANOFI AVENTIS US

--------------------------------------------------------------------------------

A076191  AB  No FEXOFENADINE HYDROCHLORIDE TABLET; ORAL 180MG FEXOFENADINE HYDROCHLORIDE BARR

--------------------------------------------------------------------------------

A076191  AB  No FEXOFENADINE HYDROCHLORIDE TABLET; ORAL 30MG FEXOFENADINE HYDROCHLORIDE BARR

--------------------------------------------------------------------------------

A076191  AB  No FEXOFENADINE HYDROCHLORIDE TABLET; ORAL 60MG FEXOFENADINE HYDROCHLORIDE BARR

--------------------------------------------------------------------------------

A076502  AB  No FEXOFENADINE HYDROCHLORIDE TABLET; ORAL 180MG FEXOFENADINE HYDROCHLORIDE DR REDDYS LABS LTD

--------------------------------------------------------------------------------

A076502  AB  No FEXOFENADINE HYDROCHLORIDE TABLET; ORAL 30MG FEXOFENADINE HYDROCHLORIDE DR REDDYS LABS LTD

--------------------------------------------------------------------------------

A076502  AB  No FEXOFENADINE HYDROCHLORIDE TABLET; ORAL 60MG FEXOFENADINE HYDROCHLORIDE DR REDDYS LABS LTD

--------------------------------------------------------------------------------

A077081  AB  No FEXOFENADINE HYDROCHLORIDE TABLET; ORAL 180MG FEXOFENADINE HYDROCHLORIDE MYLAN

--------------------------------------------------------------------------------

A077081  AB  No FEXOFENADINE HYDROCHLORIDE TABLET; ORAL 30MG FEXOFENADINE HYDROCHLORIDE MYLAN

--------------------------------------------------------------------------------

A077081  AB  No FEXOFENADINE HYDROCHLORIDE TABLET; ORAL 60MG FEXOFENADINE HYDROCHLORIDE MYLAN

--------------------------------------------------------------------------------

A076447  AB  No FEXOFENADINE HYDROCHLORIDE TABLET; ORAL 180MG FEXOFENADINE HYDROCHLORIDE TEVA

--------------------------------------------------------------------------------

A076447  AB  No FEXOFENADINE HYDROCHLORIDE TABLET; ORAL 30MG FEXOFENADINE HYDROCHLORIDE TEVA

--------------------------------------------------------------------------------

A076447  AB  No FEXOFENADINE HYDROCHLORIDE TABLET; ORAL 60MG FEXOFENADINE HYDROCHLORIDE TEVA

--------------------------------------------------------------------------------

A076236  AB  No FEXOFENADINE HYDROCHLORIDE; PSEUDOEPHEDRINE HYDROCHLORIDE TABLET, EXTENDED RELEASE; ORAL 60MG;120MG FEXOFENADINE HYDROCHLORIDE AND PSEUDOEPHEDRINE HYDROCHLORIDE BARR

--------------------------------------------------------------------------------

A079043   No FEXOFENADINE HYDROCHLORIDE; PSEUDOEPHEDRINE HYDROCHLORIDE TABLET, EXTENDED RELEASE; ORAL 180MG;240MG FEXOFENADINE HYDROCHLORIDE AND PSEUDOEPHEDRINE HYDROCHLORIDE DR REDDYS LABS LTD

--------------------------------------------------------------------------------

A076298  AB  No FEXOFENADINE HYDROCHLORIDE; PSEUDOEPHEDRINE HYDROCHLORIDE TABLET, EXTENDED RELEASE; ORAL 60MG;120MG FEXOFENADINE HYDROCHLORIDE AND PSEUDOEPHEDRINE HYDROCHLORIDE IMPAX PHARMS



III. China Domestic Market
I suggest you to look through the SFDA website to get related informations. It is not difficult.



IV. The market information is not easy to acquire. I suggest you to purchase IMS data or BMI data.
赞一下(2人) 回复此楼
3楼2011-03-18 13:36:14
已阅   回复此楼   关注TA 给TA发消息 送TA红花 TA的回帖

空城若虚

金虫 (正式写手)
非常感谢楼上的。
我主要是要查的太多了，时间比较紧，才求助的。
赞一下 回复此楼
4楼2011-03-18 20:10:17
已阅   回复此楼   关注TA 给TA发消息 送TA红花 TA的回帖
查看全部 6 个回答
普通表情 龙 兔 虎 猫 高级回复 (可上传附件)
信息提示
关闭
请填处理意见
关闭